Read Complete Article Here November 19, 2013 Health care giant Johnson & Johnson Co.’s ( JNJ ) medical-device unit DePuy Orthopaedics, Inc., announced Tuesday that it has reached a $2.5 billion settlement to compensate patients in the U.S. who were subject to a second surgery, known as revision surgery, to replace their recalled DePuy ASR Hip system. More than 12,000 thousand lawsuits were filed by patients against DePuy in federal and state courts related to the recall of its hip-implant products. The lawsuits were filed by implantees who have suffered metallosis, premature device failure, and other serious complications allegedly caused by the metal-on-metal hip devices recalled in 2010. In August 2010, DePuy Orthopaedics issued a voluntary recall of its ASR XL Acetabular Hip System and DePuy ASR Hip Resurfacing System after receiving new, then-unpublished data from a joint replacement registry in the UK. The DePuy unit recalled 93,000 implants in 2010, including 37,000 in the U.S. The recall meant that ASR implantees had to undergo a revision surgery, which caused the patients a loss of time, money and a lot of pain. It is said to have already spent nearly $1 billion on testing and treatment costs related to the recall.